These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9757685)

  • 21. [Oral beta-lactam antibiotics in the treatment of respiratory tract infections].
    Sidorenko SV
    Antibiot Khimioter; 2001; 46(7):27-33. PubMed ID: 11697241
    [No Abstract]   [Full Text] [Related]  

  • 22. Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin.
    Martinelli R; Lopes AA; de Oliveira MM; Rocha H
    Antimicrob Agents Chemother; 1981 Dec; 20(6):800-2. PubMed ID: 7034642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentin treatment of bacterial infections in hospitalised patients.
    Ellis-Pegler RB; Lang SD; Downey DJ; Anderson MP
    N Z Med J; 1982 Aug; 95(713):542-5. PubMed ID: 6752781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
    Bonafede ME; Blumer JL
    Adv Pediatr Infect Dis; 1996; 12():71-108. PubMed ID: 9033976
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of amoxycillin and clarithromycin as initial treatment of community-acquired lower respiratory tract infections.
    MacFarlane JT; Prewitt J; Gard P; Guion A
    Br J Gen Pract; 1996 Jun; 46(407):357-60. PubMed ID: 8983255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistant respiratory pathogens and extended-spectrum antibiotics.
    Pichichero ME
    Am Fam Physician; 1995 Nov; 52(6):1739-46. PubMed ID: 7484684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic prophylaxis post-tonsillectomy: is it of benefit?
    Colreavy MP; Nanan D; Benamer M; Donnelly M; Blaney AW; O'Dwyer TP; Cafferkey M
    Int J Pediatr Otorhinolaryngol; 1999 Oct; 50(1):15-22. PubMed ID: 10596882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of amoxicillin and clavulanic acid and quinolones as first choice antibiotics in uncomplicated urinary tract infections in Spain should be reviewed.
    Llor C; Aspiroz C; Cano A; Barranco M
    Aten Primaria; 2012 Jul; 44(7):443-4. PubMed ID: 22265580
    [No Abstract]   [Full Text] [Related]  

  • 32. [Respiratory tract infections: how frequent is antibiotic resistance? In vitro activity of older and recent antibiotics against the significant pathogens].
    Ruckdeschel G
    Fortschr Med; 1994 Nov; 112(33):485-8. PubMed ID: 7843673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibiotics in respiratory tract infections. Enormous differences in compliance].
    MMW Fortschr Med; 2001 Dec; 143(51-52):50-1. PubMed ID: 11824169
    [No Abstract]   [Full Text] [Related]  

  • 36. The history and background of Augmentin.
    Rolinson GN
    S Afr Med J; 1982 Jul; 62(5 Spec No):3A-4A. PubMed ID: 6979804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous activity of significant antibiotics.
    Bergogne-Bérézin E
    Clin Ther; 1991; 13(1):181-8. PubMed ID: 2029722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
    Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
    Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
    Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.